{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:40:24Z","timestamp":1790804424310,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Mach Intell"],"DOI":"10.1038\/s42256-021-00353-8","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T16:02:42Z","timestamp":1624550562000},"page":"716-726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Machine learning to guide the use of adjuvant therapies for breast cancer"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9936-7141","authenticated-orcid":false,"given":"Ahmed M.","family":"Alaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Gurdasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-8409","authenticated-orcid":false,"given":"Adrian L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jem","family":"Rashbass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"van der Schaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2017.1747","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice, C. et al. Global, regional and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 3, 524\u2013548 (2017).","journal-title":"JAMA Oncol."},{"key":"353_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1002\/cncr.31638","volume":"124","author":"F Guo","year":"2018","unstructured":"Guo, F., Kuo, Y.-f, Shih, Y. C. T., Giordano, S. H. & Berenson, A. B. Trends in breast cancer mortality by stage at diagnosis among young women in the United States. Cancer 124, 3500\u20133509 (2018).","journal-title":"Cancer"},{"key":"353_CR4","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1904819","volume":"380","author":"JA Sparano","year":"2019","unstructured":"Sparano, J. A. et al. Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer. New Engl. J. Med. 380, 2395\u20132405 (2019).","journal-title":"New Engl. J. Med."},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","volume":"25","author":"WF Symmans","year":"2007","unstructured":"Symmans, W. F. et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J. Clin. Oncol. 25, 4414\u20134422 (2007).","journal-title":"J. Clin. Oncol."},{"key":"353_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2464","volume":"12","author":"GC Wishart","year":"2010","unstructured":"Wishart, G. C. et al. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res. 12, R1 (2010).","journal-title":"Breast Cancer Res."},{"key":"353_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0852-3","volume":"19","author":"FJC dos Reis","year":"2017","unstructured":"dos Reis, F. J. C. et al. An updated predict breast cancer prognostication and treatment benefit prediction model with independent validation. Breast Cancer Res. 19, 58 (2017).","journal-title":"Breast Cancer Res."},{"key":"353_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/npjbcancer.2016.11","volume":"2","author":"SS Shachar","year":"2016","unstructured":"Shachar, S. S. & Muss, H. B. Internet tools to enhance breast cancer care. NPJ Breast Cancer 2, 16011 (2016).","journal-title":"NPJ Breast Cancer"},{"key":"353_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3322\/caac.21339","volume":"66","author":"MW Kattan","year":"2016","unstructured":"Kattan, M. W. et al. American joint committee on cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J. Clin. 66, 370\u2013374 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"353_CR10","unstructured":"Early and Locally Advanced Breast Cancer: Diagnosis and Management, NICE Guideline NG101 (National Institute for Health and Care Excellence, 2018)."},{"key":"353_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejca.2017.09.031","volume":"86","author":"MC van Maaren","year":"2017","unstructured":"van Maaren, M. C. et al. Validation of the online prediction tool PREDICT v.2.0 in the Dutch breast cancer population. Eur. J. Cancer 86, 364\u2013372 (2017).","journal-title":"Eur. J. Cancer"},{"key":"353_CR12","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1200\/JCO.2005.06.178","volume":"23","author":"IA Olivotto","year":"2005","unstructured":"Olivotto, I. A. et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J. Clin. Oncol. 23, 2716\u20132725 (2005).","journal-title":"J. Clin. Oncol."},{"key":"353_CR13","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ejca.2012.01.034","volume":"48","author":"N Bhoo-Pathy","year":"2012","unstructured":"Bhoo-Pathy, N. et al. ADJUVANT! Online is overoptimistic in predicting survival of Asian breast cancer patients. Eur. J. Cancer 48, 982\u2013989 (2012).","journal-title":"Eur. J. Cancer"},{"key":"353_CR14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/sj.bjc.6605283","volume":"101","author":"H Campbell","year":"2009","unstructured":"Campbell, H., Taylor, M., Harris, A. & Gray, A. An investigation into the performance of the ADJUVANT! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom. Br. J. Cancer 101, 1074\u20131084 (2009).","journal-title":"Br. J. Cancer"},{"key":"353_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2841-9","volume":"16","author":"H Miao","year":"2016","unstructured":"Miao, H. et al. Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia. BMC Cancer 16, 820 (2016).","journal-title":"BMC Cancer"},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1200\/JCO.2001.19.4.980","volume":"19","author":"PM Ravdin","year":"2001","unstructured":"Ravdin, P. M. et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J. Clin. Oncol. 19, 980\u2013991 (2001).","journal-title":"J. Clin. Oncol."},{"key":"353_CR17","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMp1606181","volume":"375","author":"Z Obermeyer","year":"2016","unstructured":"Obermeyer, Z. & Emanuel, E. J. Predicting the future-big data, machine learning and clinical medicine. New Engl. J. Med. 375, 1216\u20131219 (2016).","journal-title":"New Engl. J. Med."},{"key":"353_CR18","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMp1702071","volume":"376","author":"JH Chen","year":"2017","unstructured":"Chen, J. H. & Asch, S. M. Machine learning and prediction in medicine-beyond the peak of inflated expectations. New Engl. J. Med. 376, 2507\u20132509 (2017).","journal-title":"New Engl. J. Med."},{"key":"353_CR19","unstructured":"Alaa, A. & Schaar, M. AutoPrognosis: automated clinical prognostic modeling via Bayesian optimization with structured kernel learning. In Proc. 35th International Conference on Machine Learning Vol. 80, 139\u2013148 (PMLR, 2018)."},{"key":"353_CR20","unstructured":"Alaa, A. M. & van der Schaar, M. Demystifying black-box models with symbolic metamodels. In Advances in Neural Information Processing Systems 11301\u201311311 (NIPS, 2019)."},{"key":"353_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","volume":"379","author":"Early Breast Cancer Trialists Collaborative Group","year":"2012","unstructured":"Early Breast Cancer Trialists Collaborative Group Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379, 432\u2013444 (2012).","journal-title":"Lancet"},{"key":"353_CR22","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"353","author":"EH Romond","year":"2005","unstructured":"Romond, E. H. et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. New Engl. J. Med. 353, 1673\u20131684 (2005).","journal-title":"New Engl. J. Med."},{"key":"353_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29523-2","volume":"8","author":"AM Alaa","year":"2018","unstructured":"Alaa, A. M. & van der Schaar, M. Prognostication and risk factors for cystic fibrosis via automated machine learning. Sci. Rep. 8, 11242 (2018).","journal-title":"Sci. Rep."},{"key":"353_CR24","doi-asserted-by":"publisher","first-page":"e0213653","DOI":"10.1371\/journal.pone.0213653","volume":"14","author":"AM Alaa","year":"2019","unstructured":"Alaa, A. M., Bolton, T., Di Angelantonio, E., Rudd, J. H. & van Der Schaar, M. Cardiovascular disease risk prediction using automated machine learning: a prospective study of 423,604 UK biobank participants. PLoS ONE 14, e0213653 (2019).","journal-title":"PLoS ONE"},{"key":"353_CR25","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1177\/0962280213515571","volume":"25","author":"J Lambert","year":"2016","unstructured":"Lambert, J. & Chevret, S. Summary measure of discrimination in survival models based on cumulative\/dynamic time-dependent ROC curves. Stat. Methods Med. Res. 25, 2088\u20132102 (2016).","journal-title":"Stat. Methods Med. Res."},{"key":"353_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell, F. E.Jr, Lee, K. L. & Mark, D. B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 15, 361\u2013387 (1996).","journal-title":"Stat. Med."},{"key":"353_CR27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/sim.4154","volume":"30","author":"H Uno","year":"2011","unstructured":"Uno, H., Cai, T., Pencina, M. J., D\u2019Agostino, R. B. & Wei, L. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat. Med. 30, 1105\u20131117 (2011).","journal-title":"Stat. Med."},{"key":"353_CR28","unstructured":"Noone, A. et al. SEER Cancer Statistics Review, 1975\u20132015 (National Cancer Institute, 2018)."},{"key":"353_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/BF01840834","volume":"22","author":"MH Galea","year":"1992","unstructured":"Galea, M. H., Blamey, R. W., Elston, C. E. & Ellis, I. O. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res. Treat. 22, 207\u2013219 (1992).","journal-title":"Breast Cancer Res. Treat."},{"key":"353_CR30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10549-011-1366-9","volume":"128","author":"JS Michaelson","year":"2011","unstructured":"Michaelson, J. S. et al. Improved web-based calculators for predicting breast carcinoma outcomes. Breast Cancer Res. Treat. 128, 827\u2013835 (2011).","journal-title":"Breast Cancer Res. Treat."},{"key":"353_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21037\/atm.2016.10.67","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann. Transl. Med. 4, 30 (2016).","journal-title":"Ann. Transl. Med."},{"key":"353_CR32","first-page":"3","volume":"160","author":"SB Kotsiantis","year":"2007","unstructured":"Kotsiantis, S. B., Zaharakis, I. & Pintelas, P. Supervised machine learning: a review of classification techniques. Emerg. Artif. Intell. Appl. Comput. Eng. 160, 3\u201324 (2007).","journal-title":"Emerg. Artif. Intell. Appl. Comput. Eng."},{"key":"353_CR33","doi-asserted-by":"publisher","first-page":"412\u2013424","DOI":"10.5306\/wjco.v5.i3.412","volume":"5","author":"O Yersal","year":"2014","unstructured":"Yersal, O. & Barutca, S. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J. Clin. Oncol. 5, 412\u2013424 (2014).","journal-title":"World J. Clin. Oncol."},{"key":"353_CR34","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.3892\/ol.2014.2589","volume":"8","author":"SK Down","year":"2014","unstructured":"Down, S. K., Lucas, O., Benson, J. R. & Wishart, G. C. Effect of PREDICT on chemotherapy\/trastuzumab recommendations in HER2-positive patients with early-stage breast cancer. Oncol. Lett. 8, 2757\u20132761 (2014).","journal-title":"Oncol. Lett."},{"key":"353_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-908","volume":"14","author":"GC Wishart","year":"2014","unstructured":"Wishart, G. C. et al. Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer. BMC Cancer 14, 908 (2014).","journal-title":"BMC Cancer"},{"key":"353_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-017-0608-5","volume":"12","author":"B \u00c1cs","year":"2017","unstructured":"\u00c1cs, B. et al. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy. Diagn. Pathol. 12, 20 (2017).","journal-title":"Diagn. Pathol."},{"key":"353_CR37","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMsm1210043","volume":"367","author":"JH Ware","year":"2012","unstructured":"Ware, J. H., Harrington, D., Hunter, D. J. & D\u2019Agostino, R. B.Sr Missing data. New Engl. J. Med. 367, 1353\u20131354 (2012).","journal-title":"New Engl. J. Med."},{"key":"353_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1536867X0400400301","volume":"4","author":"P Royston","year":"2004","unstructured":"Royston, P. Multiple imputation of missing values. Stata J. 4, 227\u2013241 (2004).","journal-title":"Stata J."},{"key":"353_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol, E. J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 25, 44\u201356 (2019).","journal-title":"Nat. Med."},{"key":"353_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0709-9","volume":"19","author":"N Latimer","year":"2019","unstructured":"Latimer, N., Abrams, K. & Siebert, U. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring. BMC Med. Res. Methodol. 19, 69 (2019).","journal-title":"BMC Med. Res. Methodol."},{"key":"353_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11912-015-0443-3","volume":"17","author":"EL Mayer","year":"2015","unstructured":"Mayer, E. L. Targeting breast cancer with CDK inhibitors. Curr. Oncol. Rep. 17, 443 (2015).","journal-title":"Curr. Oncol. Rep."},{"key":"353_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-7161(03)23001-7","volume":"23","author":"R D\u2019Agostino","year":"2003","unstructured":"D\u2019Agostino, R. & Nam, B.-H. Evaluation of the performance of survival analysis models: discrimination and calibration measures. Handbook Stat. 23, 1\u201325 (2003).","journal-title":"Handbook Stat."}],"container-title":["Nature Machine Intelligence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00353-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T20:34:40Z","timestamp":1670099680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42256-021-00353-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":42,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1038\/s42256-021-00353-8","relation":{},"ISSN":["2522-5839"],"issn-type":[{"value":"2522-5839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}